Aclaris Therapeutics, Inc. (ACRS)
3.21
-0.07
(-2.13%)
USD |
NASDAQ |
Dec 09, 16:00
3.20
-0.01
(-0.31%)
After-Hours: 20:00
Aclaris Therapeutics Profit Margin (Quarterly): -443.0% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 9.32% |
| Puma Biotechnology, Inc. | 16.24% |
| Xencor, Inc. | -28.70% |
| Vivos Therapeutics, Inc. | -79.61% |
| CEL-SCI Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -103.9% |
| Return on Assets | -73.37% |
| Return on Invested Capital | -102.1% |
| Gross Profit Margin (Quarterly) | 25.77% |
| Operating Margin (Quarterly) | -516.8% |
| Return on Net Operating Assets | -2.94K% |